Skip to main content
Year archive

Kintor Pharmaceutical Limited — 2022 filings

All 61 regulatory filings released by Kintor Pharmaceutical Limited (9939) in 2022, sourced directly from the official regulator.

61 Filings
2022 Period
2022 filings (61)
Filing Released Lang
Next Day Disclosure Return
Share Issue/Capital Change
2022-12-16 English
COMPLETION OF TOP-UP PLACING OF EXISTING SHARES AND SUBSCRIPTION FOR SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2022-12-16 English
(1) TOP-UP PLACING OF EXISTING SHARES (2) SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE AND (3) SALE OF SHARES BY THE VENDOR
Capital/Financing Update
2022-12-11 English
INSIDE INFORMATION PROPOSED TOP-UP PLACING AND SHARE PLACEMENT ARRANGEMENTS
Capital/Financing Update
2022-12-09 English
VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL OF KX-826 FOR TREATMENT OF FEMALE AGA IN CHINA MET PRIMARY ENDPOINT
Regulatory Filings
2022-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Share Issue/Capital Change
2022-12-01 English
TOP-LINE RESULTS OF PHASE I CLINICAL TRIAL OF GT20029 IN CHINA
Regulatory Filings
2022-11-24 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-11-01 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF SUBJECT ENROLLMENT AND DOSING IN PHASE I CLINICAL TRIAL OF GT20029 IN THE U.S.
Regulatory Filings
2022-10-27 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL OF KX-826 FOR TREATMENT OF ACNE VULGARIS IN CHINA
Regulatory Filings
2022-10-16 English
GRANT OF RESTRICTED SHARES OR RESTRICTED SHARE UNITS
Transaction in Own Shares
2022-10-09 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Share Issue/Capital Change
2022-10-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Share Issue/Capital Change
2022-10-06 English
Notification Letter to Non-registered holders - Notice of Publication of 2022 Interim Report and Request Form
Report Publication Announcement
2022-09-28 English
INTERIM REPORT 2022
Interim / Quarterly Report
2022-09-28 English
Next Day Disclosure Return
Share Issue/Capital Change
2022-09-07 English
COMPLETION OF TOP-UP PLACING OF EXISTING SHARES AND SUBSCRIPTION FOR SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2022-09-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Share Issue/Capital Change
2022-09-01 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings
2022-09-01 English
CLARIFICATION ANNOUNCEMENT AND RESUMPTION OF TRADING
Capital/Financing Update
2022-08-31 English
TRADING HALT
Regulatory Filings
2022-08-31 English
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings
2022-08-31 English
(1) TOP-UP PLACING OF EXISTING SHARES (2) SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE AND (3) SALE OF SHARES BY THE VENDOR
Capital/Financing Update
2022-08-31 English
INSIDE INFORMATION PROPOSED TOP-UP PLACING AND SHARE PLACEMENT ARRANGEMENTS
Capital/Financing Update
2022-08-30 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
Interim / Quarterly Report
2022-08-29 English
DATE OF BOARD MEETING
Report Publication Announcement
2022-08-17 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF SUBJECT ENROLMENT AND DOSING IN PHASE I CLINICAL TRIAL OF GT20029 IN CHINA
Regulatory Filings
2022-08-09 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLMENT IN PHASE II CLINICAL TRIAL OF KX-826 FOR TREATMENT OF MALE AGA PATIENTS IN THE US
Regulatory Filings
2022-08-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-08-01 English
SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTION PROVISION OF LOAN
Capital/Financing Update
2022-07-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-07-04 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2022
Declaration of Voting Results & Voting Rights Announcements
2022-06-30 English
SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTION PROVISION OF LOAN
Capital/Financing Update
2022-06-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-06 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information
2022-05-30 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2022-05-30 English
(1) RE-ELECTION OF RETIRING DIRECTORS&#x3b; (2) RE-APPOINTMENT OF AUDITOR&#x3b; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; AND (4) NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2022-05-30 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2021
Environmental & Social Information
2022-05-27 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2022-05-05 English
(1) CHANGE OF DIRECTORS&#x3b; AND (2) CHANGE IN COMPOSITION OF AUDIT COMMITTEE
Board/Management Information
2022-05-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Share Issue/Capital Change
2022-05-05 English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSING IN THE UNITED STATES IN PHASE II CLINICAL TRIAL OF ALK-1 ANTIBODY AND NIVOLUMAB COMBINATION THERAPY FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA
Regulatory Filings
2022-05-04 English
ANNUAL REPORT 2021
Annual Report
2022-04-27 English
SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTION PROVISION OF LOAN
Capital/Financing Update
2022-04-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-06 English
INSIDE INFORMATION TOP-LINE RESULTS FROM PROXALUTAMIDE PHASE III CLINICAL TRIAL FOR TREATING OUTPATIENTS WITH MILD TO MODERATE COVID-19
Regulatory Filings
2022-04-06 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021
Annual Report
2022-03-25 English
DATE OF BOARD MEETING
Regulatory Filings
2022-03-11 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL OF KX-826 IN CHINA FOR THE TREATMENT OF AGA IN FEMALE PATIENTS
Regulatory Filings
2022-03-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Share Issue/Capital Change
2022-03-01 English
VOLUNTARY ANNOUNCEMENT ENROLLMENT AND DOSING OF FIRST PATIENTS IN PHASE II CLINICAL TRIAL OF KX-826 FOR AGA IN THE UNITED STATES
Regulatory Filings
2022-03-01 English
CHANGE OF JOINT COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVE AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Board/Management Information
2022-02-18 English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSING IN CHINA IN PHASE III CLINICAL TRIAL OF PROXALUTAMIDE FOR THE TREATMENT OF COVID-19 OUTPATIENTS
Regulatory Filings
2022-02-11 English
CONNECTED TRANSACTION PROVISION OF LOAN
Regulatory Filings
2022-02-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-07 English
VOLUNTARY ANNOUNCEMENT FIRST SUBJECT DOSING IN PHASE I CLINICAL TRIAL OF GT20029 (AR-PROTAC) IN THE UNITED STATES
Regulatory Filings
2022-02-03 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2022-02-03 English
CHANGE OF DIRECTORS
Board/Management Information
2022-02-03 English
VOLUNTARY ANNOUNCEMENT DOSING OF FIRST PATIENT FOR ACNE VULGARIS PHASE II CLINICAL TRIAL OF KX-826 IN CHINA
Regulatory Filings
2022-01-24 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-03 English
VOLUNTARY ANNOUNCEMENT ENROLLMENT OF FIRST PATIENT AND INITIATION OF PHASE III CLINICAL TRIAL OF KX-826 FOR TREATMENT OF AGA
Regulatory Filings
2022-01-02 English